Mabwell Says IND Application Acceptance For CDH17-Targeting ADC 7MW4911 From Both NMPA & FDA

RefinitivLess than 1 min read

Mabwell Shanghai Bioscience Co Ltd 688062:

MABWELL ANNOUNCES IND APPLICATION ACCEPTANCE FOR CDH17-TARGETING ADC 7MW4911 FROM BOTH NMPA AND FDA

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Login or create a forever free account to read this news